Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, Michigan 48202, United States.
Department of Pharmaceutical and Biomedical Sciences, University of Georgia, 250 West Green Street, Athens, Georgia 30602, United States.
J Am Chem Soc. 2020 May 20;142(20):9147-9151. doi: 10.1021/jacs.0c03763. Epub 2020 May 7.
We describe the synthesis of 10-aza-9-oxakalkitoxin, an ,,-trisubstituted hydroxylamine-based analog, or hydroxalog, of the cytotoxic marine natural product kalkitoxin in which the -NMe-O- moiety replaces a -CHMe-CH- unit in the backbone of the natural product. 10-Aza-9-oxakalkitoxin displays potent and selective cytotoxicity (IC 2.4 ng mL) comparable to that of kalkitoxin itself (IC 3.2 ng mL) against the human hepato-carcinoma cell line HepG2 over both the human leukemia cell line CEM and the normal hematopoietic CFU-GM. Like kalkitoxin, and contrary to the common expectation for hydroxylamines, 10-aza-9-oxakalkitoxin is not mutagenic.
我们描述了 10-氮杂-9-氧杂卡利毒素的合成,这是一种基于羟胺的细胞毒素海洋天然产物卡利毒素的 -,- 三取代类似物,或羟烷,其中 -NMe-O- 部分取代了天然产物骨架中的 -CHMe-CH- 单元。10-氮杂-9-氧杂卡利毒素对 HepG2 人肝癌细胞系显示出与卡利毒素本身(IC 3.2 ng/mL)相当的强效和选择性细胞毒性(IC 2.4 ng/mL),对人白血病细胞系 CEM 和正常造血 CFU-GM 的毒性均较低。与卡利毒素一样,与人们对羟胺的普遍预期相反,10-氮杂-9-氧杂卡利毒素没有致突变性。